- GlobeNewswire•20 days agoNicox completes transfer of Commercial Operations to new pan-European Ophthalmic Specialty Pharmaceutical Company led by GHO Capital
SOPHIA ANTIPOLIS, France -- Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic company, today announced the completion of the transfer of its European and International commercial ...
- The Wall Street Journal•last month
Valeant Pharmaceuticals International shareholders just can’t catch a break. Shares in the beleaguered drug maker fell nearly 7% Friday after Valeant announced that the Food and Drug Administration has ...
Nicox SA (COX.PA)
Paris - Paris Delayed Price. Currency in EUR
|Bid||10.65 x 168100|
|Ask||10.85 x 50000|
|Day's Range||10.09 - 10.33|
|52wk Range||1.55 - 13.68|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-8.24|
|Avg Vol (3m)||386,207|
|Dividend & Yield||N/A (N/A)|